Your browser doesn't support javascript.
loading
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer.
Wu, Yishuo; Yu, Hongjie; Zheng, S Lilly; Na, Rong; Mamawala, Mufaddal; Landis, Tricia; Wiley, Kathleen; Petkewicz, Jacqueline; Shah, Sameep; Shi, Zhuqing; Novakovic, Kristian; McGuire, Michael; Brendler, Charles B; Ding, Qiang; Helfand, Brian T; Carter, H Ballentine; Cooney, Kathleen A; Isaacs, William B; Xu, Jianfeng.
Afiliación
  • Wu Y; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Yu H; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Zheng SL; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Na R; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Mamawala M; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Landis T; Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Wiley K; Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Petkewicz J; Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Shah S; Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Shi Z; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois.
  • Novakovic K; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • McGuire M; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Brendler CB; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois.
  • Ding Q; Department of Surgery, NorthShore University HealthSystem, Evanston, Illinois.
  • Helfand BT; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Carter HB; Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.
  • Cooney KA; Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.
  • Isaacs WB; Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Xu J; Department of Internal Medicine, University of Utah, Salt Lake City, Utah.
Prostate ; 78(8): 607-615, 2018 06.
Article en En | MEDLINE | ID: mdl-29520813
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Quinasa de Punto de Control 2 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Quinasa de Punto de Control 2 Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Prostate Año: 2018 Tipo del documento: Article País de afiliación: China